{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:34:04Z","timestamp":1791045244529,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Artif Organs"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10047-021-01271-7","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T17:03:10Z","timestamp":1620925390000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of the whole activated clotting time during Impella support on short-term prognosis"],"prefix":"10.1007","volume":"25","author":[{"given":"Makiko","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7294-7637","authenticated-orcid":false,"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"1271_CR1","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.jacc.2015.10.017","volume":"66","author":"D Burkhoff","year":"2015","unstructured":"Burkhoff D, Sayer G, Doshi D, Uriel N. Hemodynamics of mechanical circulatory support. J Am Coll Cardiol. 2015;66:2663\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"1271_CR2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/ccd.28307","volume":"93","author":"MB Basir","year":"2019","unstructured":"Basir MB, Kapur NK, Patel K, et al. National cardiogenic shock initiative i. improved outcomes associated with the use of shock protocols: updates from the national cardiogenic shock initiative. Catheter Cardiovasc Interv. 2019;93:1173\u201383.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1271_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ccd.28560","volume":"95","author":"N Patel","year":"2020","unstructured":"Patel N, Sharma A, Dalia T, et al. Vascular complications associated with percutaneous left ventricular assist device placement: a 10-year US perspective. Catheter Cardiovas Interv. 2020;95:309\u201316.","journal-title":"Catheter Cardiovas Interv"},{"key":"1271_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MAT.0000000000000290","volume":"62","author":"AP Badiye","year":"2016","unstructured":"Badiye AP, Hernandez GA, Novoa I, Chaparro SV. Incidence of hemolysis in patients with cardiogenic shock treated with Impella percutaneous left ventricular assist device. ASAIO J. 2016;62:11\u20134.","journal-title":"ASAIO J"},{"key":"1271_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/aor.13319","volume":"43","author":"ML Esposito","year":"2019","unstructured":"Esposito ML, Morine KJ, Annamalai SK, et al. Increased plasma-free hemoglobin levels identify hemolysis in patients with cardiogenic shock and a trans valvular micro-axial flow pump. Artif Organs. 2019;43:125\u201331.","journal-title":"Artif Organs"},{"key":"1271_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/MAT.0000000000000069","volume":"60","author":"ME Davis","year":"2014","unstructured":"Davis ME, Haglund NA, Tricarico NM, et al. Development of acquired von Willebrand syndrome during short-term micro axial pump support: implications for bleeding in a patient bridged to a long-term continuous-flow left ventricular assist device. ASAIO J. 2014;60:355\u20137.","journal-title":"ASAIO J"},{"key":"1271_CR7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1051\/ject\/201850077","volume":"50","author":"M Goldfarb","year":"2018","unstructured":"Goldfarb M, Czer LS, Lam LD, et al. High molecular weight von willebrand factor multimer loss and bleeding in patients with short-term mechanical circulatory support devices: a case series. J Extra Corpor Technol. 2018;50:77\u201382.","journal-title":"J Extra Corpor Technol"},{"key":"1271_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/0897190018757148","volume":"32","author":"JN Dietrich","year":"2019","unstructured":"Dietrich JN, Kazmi H. Bleeding risks in patients on percutaneous ventricular assist devices receiving two different dextrose concentrations of heparinized purge solution: a case series. J Pharm Pract. 2019;32:464\u20139.","journal-title":"J Pharm Pract"},{"key":"1271_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.118.036614","volume":"139","author":"B Schrage","year":"2019","unstructured":"Schrage B, Ibrahim K, Loehn T, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation. 2019;139:1249\u201358.","journal-title":"Circulation"},{"key":"1271_CR10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00392-019-01458-2","volume":"108","author":"B Wernly","year":"2019","unstructured":"Wernly B, Seelmaier C, Leistner D, et al. Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock-a critical appraisal of current data. Clin Res Cardiol. 2019;108:1249\u201357.","journal-title":"Clin Res Cardiol"},{"key":"1271_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11239-019-01837-6","volume":"48","author":"L Succar","year":"2019","unstructured":"Succar L, Sulaica EM, Donahue KR, Wanat MA. Management of anticoagulation with Impella\u00ae percutaneous ventricular assist devices and review of new literature. J Thromb Thrombolysis. 2019;48:284\u201391.","journal-title":"J Thromb Thrombolysis"},{"key":"1271_CR12","doi-asserted-by":"publisher","first-page":"e0183193","DOI":"10.1371\/journal.pone.0183193","volume":"12","author":"U Flierl","year":"2017","unstructured":"Flierl U, Tongers J, Berliner D, et al. Acquired von Willebrand syndrome in cardiogenic shock patients on mechanical circulatory microaxial pump support. PLoS ONE. 2017;12:e0183193.","journal-title":"PLoS ONE"},{"key":"1271_CR13","doi-asserted-by":"publisher","first-page":"3791307","DOI":"10.1155\/2019\/3791307","volume":"2019","author":"BN Reed","year":"2019","unstructured":"Reed BN, DiDomenico RJ, Allender JE, et al. Survey of anticoagulation practices with the Impella percutaneous ventricular assist device at high-volume centers. J Interv Cardiol. 2019;2019:3791307.","journal-title":"J Interv Cardiol"},{"key":"1271_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tracli.2016.07.004","volume":"23","author":"R Copotoiu","year":"2016","unstructured":"Copotoiu R, Cinca E, Collange O, et al. Pathophysiology of hemorragic shock. Transfusion clinique et biologique: Transfus Clin Biol. 2016;23:222\u20138.","journal-title":"Transfusion clinique et biologique: Transfus Clin Biol"},{"key":"1271_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1345\/aph.1A141","volume":"36","author":"MA Smythe","year":"2002","unstructured":"Smythe MA, Koerber JM, Nowak SN, et al. Correlation between activated clotting time and activated partial thromboplastin times. Ann Pharmacother. 2002;36:7\u201311.","journal-title":"Ann Pharmacother"},{"key":"1271_CR16","doi-asserted-by":"publisher","first-page":"107602961983348","DOI":"10.1177\/1076029619833480","volume":"25","author":"JW Schurr","year":"2019","unstructured":"Schurr JW, Muske AM, Stevens CA, et al. Derivation and validation of age- and body mass index-adjusted weight-based unfractionated heparin dosing. Clin Appl Thromb Hemost. 2019;25:1076029619833480.","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Journal of Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-021-01271-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10047-021-01271-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-021-01271-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T18:22:10Z","timestamp":1699035730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10047-021-01271-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1007\/s10047-021-01271-7","relation":{},"ISSN":["1434-7229","1619-0904"],"issn-type":[{"value":"1434-7229","type":"print"},{"value":"1619-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]},"assertion":[{"value":"26 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest related to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}